Skin Disorders Archives

About Us

Bharti Rana Jayshankar – Founder

She brings in more than 30 years of experience in content building, architecture, writing, editing and storytelling. Ms Jayshankar has worked in the Economic Times daily, IBT Times, Investopedia and more than a dozen content firms as a content strategist and planner.

Jay Shankar – Co-founder

He has almost three decades of experience in journalism. He has worked with national dailies such as ET, Indian Express, The Pioneer, The Hindu, Agence France Presse and Bloomberg.

Contact Info

info@healthquill.com

Johnson & Johnson has agreed to buy the rights for an investigational skin disorder treatment from Numab Therapeutics for $1.25 billion.

J & J to buy rights for experimental skin disorder drug for $1.25 billion

Johnson & Johnson has agreed to buy the rights for an investigational skin disorder treatment from Numab Therapeutics for $1.25 billion.

by HealthQuill
May 30, 2024
0 Comments

A bacterium, staphylococcus aureus, single-handedly imbalances the equilibrium of micro-organisms, that keep the skin healthy, and cause itching, according to researchers at Harvard Medical School.

Drugs Health Pharma

Bacterium S. aureus behind happiness of having to scratch for every itch

HQ Team November 24, 2023: A bacterium, staphylococcus aureus, single-handedly imbalances the equilibrium of micro-organisms, that keep the skin healthy, and cause itching,.